Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
Study Assessments of the PSP cohortT0T1pEnergy expenditureMeasured rest energy expenditure (mREE), Kcal/day1686.20(542.84)1683.0(399.90)0.985Total daily energy expenditure (TDEE), Kcal/day2426.67 (651.09)2475.70(582.89)0.691Physical activity level (PAL)1.49(0.16)1.48(0.10)0.865PAL intensity level, n (%) < 1.40 sedentary4(26.66)3(20)0.705 1.40 to 1.69 low active8(53.33)11(73.33)0.257 1.70 to 1.99 active3(20)1(6.66)0.317 2.00 to 2.40 very active0(0)0(0)1Body composition Free fat mass, kg61.29(9.8)59.17(10.57)0.299 Free fat mass index, kg/m36.79(4.75)35.44(5.25)0.299 Fat mass, kg18.77(12.39)19.75(10.15)0.639 Fat mass index, kg/m11.34(7.77)12.0(6.54)0.599 Skeletal muscle mass, Kg31.35 (8.28)29.54 (8.29)0.419 Skeletal muscle mass index, Kg/m211.33 (2.98)10.56 (2.51)0.411 Pathologic skeletal muscle mass index, n (%)0 (0)2 (13.33)0.480 Body cellular mass, kg, median (IQR)32.65(16.6)27(9.9)0.730 Body cellular mass index, kg/m, median (IQR)19.25(7.3)16.85(5.4)0.826 Total body water, L46.31(7.82)44.79(8.46)0.441 Total body water index, L/m27.807(4.04)26.793(4.28)0.419 Extracellular water, L20.70(3.65)21.143(3.29)0.372Dietary intake Calorie intake, Kcal/day1854.87(582.78)1695.27(588.36) < 0.001 Protein intake, g/day74.16(25.11)68.75(21.29) < 0.001 Carbohydrates intake, %: Sugars, %49.73(3.08)21.53(6.56)47.07(6.95)22.73(7.49)0.5110.393Lipid intake, %: SFA, %, median (IQR): PUFA, %, median (IQR)32.00(4.03)11(3)4 (2)34.47(6.47)11(3)5(2)0.3300.2170.465 Water intake, mL/day, median (IQR)1400 (500)1400 (600)0.755 Fibers intake, g/day30.42(13.17)25.06(9.94)0.001 Calcium intake, mg/day997.80(349.04)994.33(372.98)0.008 Iron intake, intake, mg/day12.87(5.535)10.41(3.40) < 0.001 Zinc intake, mg/day10.38(4.56)9.83(2.89)0.034 Vitamin A intake, μg/day, median (IQR)1088(999)1037 (408)0.307 Vitamin D intake, μg/day, median (IQR)1.9(2.4)2.3(2)0.977 Vitamin E intake, mg/day12.72(5.13)11.15(3.78)0.006 Vitamin B12 intake, mg/day5.04(2.65)4.74(1.80)0.108 Vitamin C intake, mg/day229.27(121.68)208.67(105.09)0.170 Folate intake, μg/day414.47(196.93)354.60(121.14)0.038 Alcohol intake, g/day, median (IQR)2.6(12.4)1.7(10.3)0.255All data are expressed in mean (standard deviation), unless otherwise specifiedSignificant differences are highlighted in boldAbbreviations: PUFA Poly-unsaturated fatty acids; SFA Saturated fatty acids
Source: Results. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Study design awaiting verification.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.
Meta-analysis unclear · Blinding unclear / not reported · Research setting awaiting verification
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Longitudinal change of energy expenditure, body composition and dietary habits in Progressive Supranuclear Palsy patients
Study design awaiting verification · Neurological Sciences · 2024
Original publication title
Longitudinal change of energy expenditure, body composition and dietary habits in Progressive Supranuclear Palsy patients
© The Author(s) 2024
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: What background does the paper provide?
Alterations in metabolic status, body composition, and food intake are present in all neurodegenerative diseases. Aim of this study was to detect the progression of these changes in Progressive Supranuclear Palsy (PSP).
Source: IntroductionAbstract: What methods does the paper describe?
We conducted a longitudinal study of 15 patients with PSP. The assessments were performed at baseline (T0) and after 7(IQR = 5) months of follow-up (T1). We collected anthropometric measures including body weight, height, body mass index and waist circumference, metabolic parameters through indirect calorimeters, body composition using bioimpedance analysis, and dietary habits with a validated questionnaire. PSP-rating scale (PSP-rs) was used to evaluate disease severity and dysphagia.
Source: MethodsAbstract: Results
The majority of patients (66.66%) presented PSP-Richardson Syndrome and 33.33% the other variant syndromes of the disease. At T1 there was a decrease in intake of total daily calories (p < 0.001), proteins (p < 0.001), fibers (p = 0.001), calcium (p = 0.008), iron (p < 0.001), zinc (0.034), vitamin E (p = 0.006) and folates (p = 0.038) compared to T0. No other changes were found. As for T1 data, no significant differences were shown according to disease phenotypes or the presence of clinically significant dysphagia for solids.
Source: ResultsAbstract: Conclusions
Within a mid-term follow up, PSP patients presented reduced caloric and proteins intake regardless the presence of dysphagia. The PSP-rs is likely not adequate to assess dysphagia, which should be investigated by specific clinical scales or instrumental examinations. With the goal of maintaining adequate nutritional status, the administration of protein and vitamin supplements should be considered even in the absence of dysphagia evidenced by the rating scales.
Source: ConclusionsAuthors’ abstract
Introduction
Alterations in metabolic status, body composition, and food intake are present in all neurodegenerative diseases. Aim of this study was to detect the progression of these changes in Progressive Supranuclear Palsy (PSP).
Methods
We conducted a longitudinal study of 15 patients with PSP. The assessments were performed at baseline (T0) and after 7(IQR = 5) months of follow-up (T1). We collected anthropometric measures including body weight, height, body mass index and waist circumference, metabolic parameters through indirect calorimeters, body composition using bioimpedance analysis, and dietary habits with a validated questionnaire. PSP-rating scale (PSP-rs) was used to evaluate disease severity and dysphagia.
Results
The majority of patients (66.66%) presented PSP-Richardson Syndrome and 33.33% the other variant syndromes of the disease. At T1 there was a decrease in intake of total daily calories (p < 0.001), proteins (p < 0.001), fibers (p = 0.001), calcium (p = 0.008), iron (p < 0.001), zinc (0.034), vitamin E (p = 0.006) and folates (p = 0.038) compared to T0. No other changes were found. As for T1 data, no significant differences were shown according to disease phenotypes or the presence of clinically significant dysphagia for solids.
Conclusions
Within a mid-term follow up, PSP patients presented reduced caloric and proteins intake regardless the presence of dysphagia. The PSP-rs is likely not adequate to assess dysphagia, which should be investigated by specific clinical scales or instrumental examinations. With the goal of maintaining adequate nutritional status, the administration of protein and vitamin supplements should be considered even in the absence of dysphagia evidenced by the rating scales.
Supplementary Information
The online version contains supplementary material available at 10.1007/s10072-024-07533-5.
Publication and source details
Original title: Longitudinal change of energy expenditure, body composition and dietary habits in Progressive Supranuclear Palsy patients
Maria Francesca Tepedino; Anna Rosa Avallone; Filomena Abate; Marina Serio; Miriam Caterino; Roberto Erro; Maria Teresa Pellecchia; Paolo Barone; Marina Picillo
Neurological Sciences · 2024
© The Author(s) 20242024https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.Università degli Studi di SalernoOpen access funding provided by Università degli Studi di Salerno within the CRUI-CARE Agreement.
Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-11T12:07:07.336699+00:00
DOI: 10.1007/s10072-024-07533-5 · PMC11306440